Lindy Durrant receives Waldenström award from the Swedish Society of Oncology
LONDON: Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer, is delighted to announce that Professor Lindy Durrant, Scancell’s Chief Scientific Officer, is to receive the…